Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
Trial status: Open for Enrollment
Why is this study being done?
This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
Who is eligible to participate?
- Age equal to or greater than 18 years of age.
- Scheduled to have cardiac bypass surgery at Mayo Clinic in Rochester, MN or Duke University Medical Center in Raleigh, NC
- At risk for needing at least 4 units of blood during/after surgery